The SARS-CoV-2 pandemic has highlighted the critical need for rapid and precise diagnostic methodologies. Conventional testing approaches often exhibit limitations in terms of speed, accessibility, and sensitivity. To address these constraints, we propose an advanced graphene-based biosensing platform for SARS-CoV-2 detection. This sensor integrates advanced nanophotonic principles, metamaterial physics, and two-dimensional material properties to achieve enhanced sensitivity through the detection of refractive index perturbations induced by SARS-CoV-2 biomolecules. Electromagnetic simulations were conducted to optimize the sensor design. The resulting configuration demonstrates a sensitivity of 1800 nmRIU−1 and a detection limit of 0.007 RIU. The sensor exhibits multi-wavelength sensing capabilities at 3.942 μm, 4.018 μm, 4.088 μm, and 4.201 μm, with a high figure of merit of 104.167 RIU−1 and quality factors ranging from 65.766 to 251. 750.The sensor's multilayer architecture, comprising tungsten, graphene, and strontium titanate synergistically enhances both sensitivity and selectivity. Its compact form factor and capacity for real-time analysis render it a promising candidate for point-of-care COVID-19 diagnostics.
Read full abstract